Most Read Articles
Pearl Toh, 13 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 5 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
Yesterday
Rates of immunization particularly in a primary care setting can be improved by constant patient reminders and recall systems, a recent study has found.
Roshini Claire Anthony, 2 days ago

The combination of ceftazidime and avibactam proved noninferior to meropenem in adults with nosocomial pneumonia, positioning it as a potential treatment option for this condition, results from the phase III REPROVE* trial show. Nonetheless, the combination was associated with a higher number of safety events compared with meropenem.

Battle of microperimeters: CenterVue MAIA vs Nidek MP-3

10 Jan 2018

Values generated by the CenterVue Macular Integrity Assessment (MAIA) vs the Nidek Microperimetry-3 (MP-3) microperimeter are higher for retinal sensitivity but lower for luminance and contrast sensitivity, suggests a recent study.

However, the relationships appear fairly consistent, and application of a standard correction factor allows data to be inter-related, at least for normal eyes, according to the investigators.

The mean retinal sensitivity measures were significantly lower (p<0.0001) with the MP-3 (25.02±1.06 dB; range, 20.90–26.70) compared with the MAIA (30.68±0.74 dB; range, 28–31.84). The luminosity levels measured by the MP-3 (7.75±1.31 asb; range, 6.44–9.06) were significantly higher (p<0.0001) vs those of the MAIA (0.92±0.14 asb; range, 0.78–1.06). The MP-3 (0.94±0.33 log units; range, 0.61–1.27) also measured significantly higher contrast sensitivity compared with the MAIA (0.23±0.03 log units; range, 0.20–0.26).

The intraclass coefficient between the two instruments, despite the absolute differences, was 0.85 (95 percent CI, 0.70‒0.92) after applying a standard correction factor to each data point (MAIA sensitivity=MP-3 sensitivity+5.65), with a mean difference of 0.01 between MP-3 and MAIA.

The investigators conducted a prospective comparative study on 31 eyes of 23 healthy participants who underwent complete ophthalmological examination including retinal sensitivity assessments using two microperimeters: the MP-3 by Nidek Technologies and the MAIA by CenterVue. They analysed the mean retinal sensitivity as well as its corresponding luminance and contrast between the two devices. Interdevice reproducibility and level of agreement between the sensitivity values of the devices were also evaluated.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 13 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 5 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
Yesterday
Rates of immunization particularly in a primary care setting can be improved by constant patient reminders and recall systems, a recent study has found.
Roshini Claire Anthony, 2 days ago

The combination of ceftazidime and avibactam proved noninferior to meropenem in adults with nosocomial pneumonia, positioning it as a potential treatment option for this condition, results from the phase III REPROVE* trial show. Nonetheless, the combination was associated with a higher number of safety events compared with meropenem.